Drug Trial Radar · NCT04937530
RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY
Last checked: Nov 19, 2026Latest source record: Jun 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
40
Planned (sponsor's estimate)
Start
Jun 23, 2021
Primary completion
Jul 30, 2022
Study completion Aug 30, 2022
Sponsor
- Lead sponsor
- Biojiva LLCIndustry
- Sponsor type
- Industry
- First posted
- Jun 24, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, placebo-controlled trial of RT001 in patients with PSP.
Conditions
- Progressive Supranuclear Palsy
Interventions
RT001Drug
RT001 8.64 g/d (3 capsules TID) for 1 month followed by 5.76 g/d (3 capsules BID) for an additional 11 months
PlaceboDrug
Placebo Comparator: Placebo Inactive comparator capsule 960 mg/capsule: 3 capsules TID for 4 weeks, followed by 3 capsules BID for the remaining 44 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in the PSPRS-28 at 48 weeks for the RT001 treated group vs placebo-treated groupTime frame: 48 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Agaharied Teaching Hospital, University of Munich
Munich, MD, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.